glp-1 receptor agonist with dpp-4 inhibitor combination not recommended do combine inhibitors agonists guidance What classes of diabetes do not combine dpp-4 inhibitors
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] Mller FS, Hegelund ER
Weight loss averages 60-80% of excess weight
Both medications are preferred options for diabetic patients with or at risk for cardiovascular disease
That includes nausea, reflux, and dehydration risk
Losing more than 12 pounds per week can increase the risk of gallstones, hair loss and muscle loss
